Evidence map›Paper›PMID 28805677›Full record

ArticleInternational journal of molecular sciences2017

Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells.

Xiaoming Chen, Alyssa Cobbs, Jasmine George, Ashmeer Chima, Fidele Tuyishime, Xueying Zhao

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Emerging roles of proximal tubular endocytosis in renal fibrosis.Frontiers in cell and developmental biology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells.International journal of physiology, pathophysiology and pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoming ChenDepartment of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. xachen@msm.edu.
Alyssa CobbsDepartment of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. acobbs@msm.edu.
Jasmine GeorgeDepartment of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. Jgeorge@msm.edu.
Ashmeer ChimaDepartment of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. achima@msm.edu.
Fidele TuyishimeDepartment of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. ftuyishime@msm.edu.
Xueying ZhaoDepartment of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA. xzhao@msm.edu.
Morehouse School of Medicine · US

Funding

TRANSCRIPTION FACTORS AND PROSTATE CANCERG12RR003034 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI BOND, VINCENT C · 1986 to 2011
$32.4M
Research Desogn and Biostatistics CoreU54MD007588 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI OFILI, ELIZABETH O. · 2012 to 2018
$24.8M
TRANSPLANTATION OF EXOSOMES FROM HYPOXIA-PRECONDITIONED ADIPOSE-DERIVED STEM CELLS PROMOTES ANGIOGENESIS IN ISCHEMIC HEARTG12MD007602 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI BOND, VINCENT C · 2012 to 2017
$18.4M
WARCEFU54RR026137 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI CONERLY HOLLIDAY, RHONDA C · 2009 to 2011
$14.6M
Kidney injury molecule-1 in diabetic nephropathySC1DK112151 · NIDDK · MOREHOUSE SCHOOL OF MEDICINE · PI ZHAO, XUEYING · 2016 to 2019
$1.4M
KIM-1, microparticles and diabetic tubular injurySC2DK096441 · NIDDK · MOREHOUSE SCHOOL OF MEDICINE · PI ZHAO, XUEYING · 2012 to 2014
$420k
NCRR NIH HHS G12 RR003034NCRR NIH HHS U54 RR026137NIDDK NIH HHS SC1 DK112151NIDDK NIH HHS SC2 DK096441NIMHD NIH HHS G12 MD007602NIMHD NIH HHS U54 MD007588
6 · The paper itself

Abstract

Matrix metalloproteinase-9 (MMP-9) is dysregulated in chronic kidney diseases including diabetic nephropathy. This study was performed to examine the expression of MMP-9 in renal tubule epithelial cells (TECs) under diabetic conditions and its regulatory mechanisms. We characterized MMP-9 protein in diabetic animals and primary cultured rat TECs exposed to exogenous albumin and high glucose. We also used specific inhibitors to determine if internalization of albumin and/or extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation were required for MMP-9 secretion. Immunostaining of kidney sections revealed enhanced MMP-9 signal in the damaged proximal tubules in Zucker diabetic fatty (ZDF) rats. ZDF rats also exhibited an albuminuria-related and age-dependent increase in MMP-9 excretion, which was prevented by rosiglitazone. In primary cultured rat TECs, high glucose exposure did not increase MMP-9 secretion. In contrast, administration of rat serum albumin (RSA, 0.1-0.5 mg/mL) resulted in a dose-dependent increase in MMP-9 expression and secretion by TECs, which was abolished in the presence of an ERK1/2-specific inhibitor, U0126. Simvastatin, an inhibitor of albumin endocytosis, also prevented MMP-9 secretion. Taken together, these results demonstrate that endocytosis of albumin stimulates MMP-9 secretion by TECs through the ERK signaling pathway.

Indexed as

EndocytosisMAP Kinase Signaling SystemAlbuminuriaAnimalsCells, CulturedDiabetes Mellitus, ExperimentalDiabetic NephropathiesEnzyme ActivationGlucoseKidney Tubules, ProximalMaleMatrix Metalloproteinase 9RatsRats, ZuckerSerum AlbuminGlucoseMatrix Metalloproteinase 9Serum Albuminalbuminuriachronic kidney diseasediabetesMMP-9simvastatinU0126

Identifiers

PMID28805677
PMCPMC5578147
OpenAlexW2745033466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.